These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3898281)

  • 1. Thymopentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies.
    Grob PJ; Binswanger U; Blumberg A; Gloor HJ; Hany A; Herwig W; Iselin H; Zàruba K; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():107-15. PubMed ID: 3898281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
    Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
    Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination.
    Dumann H; Meuer SC; Renschin G; Köhler H
    Nephron; 1990; 55(2):136-40. PubMed ID: 2194133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin as adjuvant therapy to hepatitis B vaccination in formerly non-or hyporesponding hemodialysis patients.
    Zàruba K; Grob PJ; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():102-6. PubMed ID: 3898280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brief treatment with thymopentin as adjuvant in vaccination for hepatitis B: controlled study in patients on periodic hemodialysis].
    Palestini M; Messina A; Ciaraffo F; De Sanctis GM; Errera G; Corradini SG
    Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):135-9. PubMed ID: 2080311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
    Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
    J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination.
    Záruba K; Rastorfer M; Grob PJ; Joller-Jemelka H; Bolla K
    Lancet; 1983 Nov; 2(8361):1245. PubMed ID: 6139582
    [No Abstract]   [Full Text] [Related]  

  • 11. [Telethermographic evaluation of the intra-articular administration of thymopentin in rheumatoid arthritis of the knee].
    Pappalardo A; Sallì L; Campisi D; Scalici G; Di Marco C; Martorana U
    Clin Ter; 1989 Mar; 128(5):321-7. PubMed ID: 2524320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
    Molin L; Schmid F; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation with thymopentin in humans.
    Bolla K; Duchateau J; Delespesse G; Servais G
    Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.
    Molin L; Schmid F; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S; Alavian SM; Hajarizadeh B
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of thymopentin in severely burned patients.
    Waymack JP; Jenkins M; Warden GD; Solomkin J; Law E; Hummel R; Miller A; Alexander JW
    Surg Gynecol Obstet; 1987 May; 164(5):423-30. PubMed ID: 3554564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
    Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
    Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients.
    Pagani S; Cruciani L; Chianelli M; Procaccini E; Pozzilli P
    Diabetes Res; 1989 Dec; 12(4):199-201. PubMed ID: 2534655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymopentin in the treatment of recurrent condylomata acuminata].
    Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
    Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.